Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CORONARY THROMBOLYSIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 314 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Estess, JM; Moliterno, DJ
      Thrombolytic therapy for acute myocardial infarction

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Antman, EM; de Lemos, JA; Braunwald, E
      Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    3. Dey, S; Chitte, RR
      A new thrombolytic enzyme for acute myocardial infarction

      MEDICINAL CHEMISTRY RESEARCH
    4. Sobel, BE
      Fibrin specificity of plasminogen activators, rebound generation of thrombin, and their therapeutic implications

      CORONARY ARTERY DISEASE
    5. Chern, I; Sharma, A; Dennis, D
      Concurrent use of reteplase and lepirudin in the treatment of acute anterior wall myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    6. Aoki, S; Shimizu, N; Shimonishi, M; Kitagawa, M; Okumura, K; Tanigawara, Y
      Influence of sugar chain on fibrin affinity of recombinant t-PA

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    7. Scrutinio, D; Cimminiello, C; Marubini, E; Pitzalis, MV; Di Biase, M; Rizzon, P
      Ticlopidine versus aspirin after myocardial infarction (STAMI) trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    8. Aoki, S; Kitagawa, M; Okumura, K
      Pharmacokinetic studies of Gln117 tissue-type plasminogen activator in rats

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    9. Voipio, V; Kuisma, M; Alaspaa, A; Manttari, M; Rosenberg, P
      Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest

      RESUSCITATION
    10. Coussement, PK; Bassand, JP; Convens, C; Vrolix, M; Boland, J; Grollier, G; Michels, R; Vahanian, A; Vanderheyden, M; Rupprecht, HJ; Van de Werf, F
      A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study

      EUROPEAN HEART JOURNAL
    11. Llevadot, J; Giugliano, RP; Antman, EM
      Bolus fibrinolytic therapy in acute myocardial infarction

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    12. Eikelboom, JW; Mehta, SR; Pogue, J; Yusuf, S
      Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials -Intracranial hemorrhage in trials of bolus thrombolytic therapy

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    13. Shieh, SJ; Chiu, HY; Shi, GY; Wu, CM; Wang, JC; Chen, CH; Wu, HL
      A novel platelet-rich arterial thrombosis model in rabbits - Simple, reproducible, and dynamic real-time easurement by using double-opposing inverted-sutures model

      THROMBOSIS RESEARCH
    14. Sinnaeve, P; Van de Werf, F
      Thrombolytic therapy - State of the art

      THROMBOSIS RESEARCH
    15. Rebello, SS; Kasiewski, CJ; Bentley, RG; Morgan, SR; Chu, V; Bostwick, JS; Klein, SI; Perrone, MH; Leadley, RJ
      Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs

      THROMBOSIS RESEARCH
    16. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1

      CIRCULATION
    17. Callahan, KP; Malinin, AI; Gurbel, PA; Alexander, JH; Granger, CB; Serebruany, VL
      Platelet function and fibrinolytic agents: Two sides of a coin?

      CARDIOLOGY
    18. Rebello, SS; Bentley, RG; Morgan, SR; Kasiewski, CJ; Chu, V; Perrone, MH; Leadley, RJ
      Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

      BRITISH JOURNAL OF PHARMACOLOGY
    19. Giugliano, RP; McCabe, CH; Antman, EM; Cannon, CP; Van de Werf, F; Wilcox, RG; Braunwald, E
      Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage

      AMERICAN HEART JOURNAL
    20. Collen, D; Lijnen, HR
      Recent developments in thrombolytic therapy

      FIBRINOLYSIS & PROTEOLYSIS
    21. Priglinger, U; Huber, K
      Thrombolytic therapy in acute myocardial infarction

      DRUGS & AGING
    22. Iqbal, O; Messmore, H; Hoppensteadt, D; Fareed, J; Wehrmacher, T
      State-of-the-art review - Thrombolytic drugs in acute myocardial infarction

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    23. Sauaia, A; Ralston, D; Schluter, WW; Marciniak, TA; Havranek, EP; Dunn, TR
      Influencing care in acute myocardial infarction: A randomized trial comparing 2 types of intervention

      AMERICAN JOURNAL OF MEDICAL QUALITY
    24. Davidian, MM; Powell, A; Benenati, JF; Katzen, BT; Becker, GJ; Zemel, G
      Initial results of reteplase in the treatment of acute lower extremity arterial occlusions

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    25. Laird, JR
      Pharmacologic therapies in the treatment of peripheral vascular disease: Clinical experience with reteplase, a third-generation thrombolytic

      JOURNAL OF INVASIVE CARDIOLOGY
    26. Gurewich, V
      Fibrinolysis: an unfinished agenda

      BLOOD COAGULATION & FIBRINOLYSIS
    27. Binbrek, A; Rao, N; Absher, PM; Van de Werf, F; Sobel, BE
      The relative rapidity of recanalization induced by recombinant tissue-typeplasminogen activator (r-tPA) and TNK-tPA, assessed with enzymatic methods

      CORONARY ARTERY DISEASE
    28. Sabatine, MS; Tu, TM; Jang, IK
      Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    29. Aoki, S; Shimizu, N; Koyama, J; Kato, Y; Kitagawa, M; Okumura, K; Tanigawara, Y
      Influence of N-terminal peptide and oligosaccharide on the clearance of t-PA

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    30. Antman, EM; Gibson, CM; de Lemos, JA; Giugliano, RP; McCabe, CH; Coussement, P; Menown, I; Nienaber, CA; Rehders, TC; Frey, NJ; Van der Wieken, R; Andresen, D; Scherer, J; Anderson, K; Van de Werf, F; Braunwald, E
      Combination reperfusion therapy with abciximab and reduced dose reteplase:results from TIMI 14

      EUROPEAN HEART JOURNAL
    31. Mehta, SR; Eikelboom, JW; Yusuf, S
      Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis

      LANCET
    32. Harder, S; Klinkhardt, U
      Thrombolytics - Drug interactions of clinical significance

      DRUG SAFETY
    33. Rebello, SS; Blank, HS; Lucchesi, BR
      Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis

      THROMBOSIS RESEARCH
    34. Huber, K
      Increase of efficacy of thrombolytic therapy in acute myocardial infarction by improvement of the characteristics of new fibrinolytic agents

      WIENER KLINISCHE WOCHENSCHRIFT
    35. Brass, LM; Lichtman, JH; Wang, Y; Gurwitz, JH; Radford, MJ; Krumholz, HM
      Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction - Results from the cooperative cardiovascular project

      STROKE
    36. Yoshida, Y; Hirai, M; Yamada, T; Tsuji, Y; Kondo, T; Inden, Y; Akahoshi, M; Murakami, Y; Tsuda, M; Tsuboi, N; Hirayama, H; Okamoto, M; Ito, T; Saito, H; Toyama, J
      Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias - Evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias

      CIRCULATION
    37. Pratico, D; Cyrus, T; Li, HW; FitzGerald, GA
      Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis

      BLOOD
    38. McRedmond, JP; Harriott, P; Walker, B; Fitzgerald, DJ
      Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1

      BLOOD
    39. Verstraete, M
      Third-generation thrombolytic drugs

      AMERICAN JOURNAL OF MEDICINE
    40. DeGeare, VS; Stone, GW; Grines, L; Brodie, BR; Cox, DA; Garcia, E; Wharton, TP; Boura, JA; O'Neill, WW; Grines, CL
      Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials)

      AMERICAN JOURNAL OF CARDIOLOGY
    41. Fleming, TR
      Design and interpretation of equivalence trials

      AMERICAN HEART JOURNAL
    42. Califf, RM
      Combination therapy for acute myocardial infarction: Fibrinolytic therapy and glycoprotein IIb/IIIa inhibition

      AMERICAN HEART JOURNAL
    43. Baron, EM; Burke, JA; Akhtar, N; Young, WF
      Spinal epidural hematoma associated with tissue plasminogen activator treatment of acute myocardial infarction

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    44. Stahr, P; Rupprecht, HJ; Voigtlander, T; Post, F; Otto, M; Erbel, R; Meyer, J
      A new thrombectomy catheter device (AngioJet) for the disruption of thrombi: An in vitro study

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    45. Pislaru, SV; Van de Werf, FJ
      The current role of thrombolytic therapy in the treatment of acute myocardial infarction

      FIBRINOLYSIS & PROTEOLYSIS
    46. Smith, BJ
      Thrombolysis in acute myocardial infarction: analysis of studies comparingaccelerated t-PA and streptokinase

      JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    47. Vogt, A
      Antiplatelet drugs plus thrombolysis in myocardial infarction - Where are we now?

      BIODRUGS
    48. Holper, EM; Giugliano, RP; Antman, EM
      Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction

      CORONARY ARTERY DISEASE
    49. Michels, HR; Hoffman, JJML; Bar, FWHM
      Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: Comparison of infusion, single-bolus, and split-bolus administration

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    50. Maksimenko, AV; Tischenko, EG
      New thrombolytic strategy: Bolus administration of tPA and urokinase-fibrinogen conjugate

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    51. Cannon, CP
      Overcoming thrombolytic resistance - Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    52. French, JK; Hyde, TA; Patel, H; Amos, DJ; McLaughlin, SC; Webber, BJ; White, HD
      Survival 12 years after randomization to streptokinase: The influence of thrombolysis in myocardial infarction flow at three to four weeks

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    53. Weitz, JI; Stewart, RJ; Fredenburgh, JC
      Mechanism of action of plasminogen activators

      THROMBOSIS AND HAEMOSTASIS
    54. Ruef, J; Nordt, TK; Peter, K; Runge, MS; Kubler, W; Bode, C
      A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation

      THROMBOSIS AND HAEMOSTASIS
    55. Sakharov, DV; Barrett-Bergshoeff, M; Hekkenberg, RT; Rijken, DC
      Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: Comparison of nine plasminogenactivators in vitro

      THROMBOSIS AND HAEMOSTASIS
    56. Brophy, JM; Joseph, L; Theroux, P
      Medical decision making in the choice of a thrombolytic agent for acute myocardial infarction

      MEDICAL DECISION MAKING
    57. Van de Werf, FJ
      The ideal fibrinolytic: can drug design improve clinical results?

      EUROPEAN HEART JOURNAL
    58. Hasdai, D; Holmes, DR; Topol, EJ; Berger, PB; Criger, DA; Hochman, JS; Bates, ER; Vahanian, A; Armstrong, PW; Wilcox, R; Ohman, EM; Califf, RM
      Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase - Results fromGUSTO-III

      EUROPEAN HEART JOURNAL
    59. Ross, AM
      New plasminogen activators: A clinical review

      CLINICAL CARDIOLOGY
    60. Westermark, S; Wiksell, H; Elmqvist, H; Hultenby, K; Berglund, H
      Effect of externally applied focused acoustic energy on clot disruption invitro

      CLINICAL SCIENCE
    61. Maksimenko, AV
      Third-generation plasminogen activators: A new direction in research

      BIOORGANICHESKAYA KHIMIYA
    62. Patel, SC; Mody, A
      Cerebral hemorrhagic complications of thrombolytic therapy

      PROGRESS IN CARDIOVASCULAR DISEASES
    63. Zhang, YL; Hervio, L; Strandberg, L; Madison, EL
      Distinct contributions of residue 192 to the specificity of coagulation and fibrinolytic serine proteases

      JOURNAL OF BIOLOGICAL CHEMISTRY
    64. Antman, EM; Giugliano, RP; Gibson, CM; McCabe, CH; Coussement, P; Kleiman, NS; Vahanian, A; Adgey, AAJ; Menown, I; Rupprecht, HJ; Van der Wieken, R; Ducas, J; Scherer, J; Anderson, K; Van de Werf, F; Braunwald, E
      Abciximab facilitates the rate and extent of thrombolysis - Results of thethrombolysis in myocardial infarction (TIMI) 14 trial

      CIRCULATION
    65. Moser, M; Nordt, T; Peter, K; Ruef, J; Kohler, B; Schmittner, M; Smalling, R; Kubler, W; Bode, C
      Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase

      CIRCULATION
    66. Helft, G; Elalamy, I; Beygui, F; Dambrin, G; Lecompte, T; Le Pailleur, C; Le Feuvre, C; Metzger, JP; Vacheron, A; Samama, MM
      New thrombolytic agents in myocardial infarction.

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    67. Roberts, WC; Sobel, BE
      Burton Elias Sobel, MD: A conversation with the editor

      AMERICAN JOURNAL OF CARDIOLOGY
    68. Van de Werf, F
      What do new lytics add to t-PA?

      AMERICAN HEART JOURNAL
    69. Califf, RM
      Glycoprotein IIb IIIa blockade and thrombolytics: Early lessons from the SPEED and GUSTO IV trials

      AMERICAN HEART JOURNAL
    70. MCMECHAN SR; ADGEY AAJ
      OPTIMAL THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION - BOLUS ADMINISTRATION

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    71. ROSS AM
      REPERFUSION THERAPY FOR MYOCARDIAL-INFARCTION - PRINCIPLES ESTABLISHED, APPLICATION STILL EVOLVING

      FIBRINOLYSIS & PROTEOLYSIS
    72. GULBA DC; BODE C; RUNGE MS; HUBER K
      THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW

      FIBRINOLYSIS & PROTEOLYSIS
    73. Meyer, J
      Clinical profile of saruplase: angiographic findings

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    74. Betriu, A
      Clinical profile of saruplase: mortality and safety

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    75. GUREVITZ O; GOLDFARB A; HOD H; FELDMAN M; SHENKMAN B; VARON D; ELDAR M; INBAL A
      RECOMBINANT VON-WILLEBRAND-FACTOR FRAGMENT AR545C INHIBITS PLATELET-AGGREGATION AND ENHANCES THROMBOLYSIS WITH RTPA IN A RABBIT THROMBOSIS MODEL

      Arteriosclerosis, thrombosis, and vascular biology
    76. GERSHLICK AH; MORE RS
      RECENT ADVANCES - TREATMENT OF MYOCARDIAL-INFARCTION

      BMJ. British medical journal
    77. MICHELS HR
      THE IMPORTANCE OF SARUPLASE IN THE CONTEXT OF OTHER THROMBOLYTIC MEDICATIONS

      Reviews in contemporary pharmacotherapy
    78. ZEYMER U; MATEBLOWSKI M; NEUHAUS KL
      THROMBIN GENERATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH FRONT-LOADED RT-PA AND RECOMBINANT HIRUDIN (HBW-023)

      Journal of thrombosis and thrombolysis
    79. SALVIONI A; PEREGO GB; MARENZI G; GALLI S; ASSANELLI E; GUAZZI MD
      PLATELET ACTIVITY IN THE EARLY-STAGE OF ACUTE MYOCARDIAL-INFARCTION -RELATION TO TIME OF PRESENTATION, TREATMENT WITH EITHER TISSUE-PLASMINOGEN ACTIVATOR OR STREPTOKINASE AND CYCLOOXYGENASE INHIBITION

      Journal of thrombosis and thrombolysis
    80. KANMATSUSE K; NAGAO K; KIKUSHIMA K; SHIOIRI K
      SYMPOSIUM ON MEDICAL DISEASES AND ANTITHROMBOTIC THERAPY - 1 - ANTITHROMBOLYTIC THERAPY FOR SCLEROTIC DISEASES - 3) ISCHEMIC-HEART-DISEASE (CORONARY THROMBOLYSIS)

      Internal medicine
    81. FRENCH JK; HYDE TA; WHITE HD
      LEFT-VENTRICULAR FUNCTION FOLLOWING THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION

      Journal of interventional cardiology
    82. GURBEL PA; SEREBRUANY VL; SHUSTOV AR; BAHR RD; CARPO C; OHMAN EA; TOPOL EJ
      EFFECTS OF RETEPLASE AND ALTEPLASE ON PLATELET-AGGREGATION AND MAJOR RECEPTOR EXPRESSION DURING THE FIRST 24 HOURS OF ACUTE MYOCARDIAL-INFARCTION TREATMENT

      Journal of the American College of Cardiology
    83. WHITE HD
      THROMBOLYTIC THERAPY AND EQUIVALENCE TRIALS

      Journal of the American College of Cardiology
    84. HAYES OW
      EMERGENCY MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION - FOCUS ON PHARMACOLOGICAL THERAPY

      Emergency medicine clinics of North America
    85. CURZEN N; HAQUE R; TIMMIS A
      APPLICATIONS OF THROMBOLYTIC THERAPY

      Intensive care medicine
    86. DESCHENES I; FINKLE CD; WINOCOUR PD
      EFFECTIVE USE OF BCH-2763, A NEW POTENT INJECTABLE DIRECT THROMBIN INHIBITOR, IN COMBINATION WITH TISSUE-PLASMINOGEN ACTIVATOR (TPA) IN A RAT ARTERIAL THROMBOLYSIS MODEL

      Thrombosis and haemostasis
    87. KAWASAKI T; SATO K; HIRAYAMA F; KOSHIO H; TANIUCHI Y; MATSUMOTO Y
      EFFECT OF A SYNTHETIC FACTOR XA INHIBITOR, YM-60828, ON BLOOD-VESSEL PATENCY IN COMBINATION WITH A THROMBOLYTIC AGENT AND ON BLOOD-LOSS FROM THE OPERATION SITE IN A RAT MODEL OF ARTERIAL THROMBOSIS

      Thrombosis and haemostasis
    88. Nordt, TK; Moser, M; Kohler, B; Ruef, J; Peter, K; Kubler, W; Bode, C
      Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction

      THROMBOSIS AND HAEMOSTASIS
    89. SITGES M; BOSCH X; BETRIU A
      OPTIMIZING THROMBOLYTIC TREATMENT IN ACUT E MYOCARDIAL-INFARCTION - ROLE OF NEW AGENTS AND THEIR ASSOCIATION WITH NEW ANTITHROMBOTIC THERAPIES

      Revista espanola de cardiologia
    90. DEPERALTA GT; LAZARO RB
      REVASCULARIZATION SURGERY IN THE ACUTE-PHASE OF ACUTE MYOCARDIAL-INFARCTION

      Revista espanola de cardiologia
    91. MEISTER FL; STRINGER KA; SPINLER SA; GONZALEZ E; TALBERT RL; WEINER B; GUERRERO RM; SMITH R
      THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION

      Pharmacotherapy
    92. STRINGER KA
      TIMI GRADE FLOW, MORTALITY, AND THE GUSTO-III TRIAL

      Pharmacotherapy
    93. MODI NB; LIN YS; REYNOLDS T; SHAHEEN A; CHRISTIAN BJ
      PHARMACOKINETICS AND PHARMACODYNAMICS OF SIBRAFIBAN (RO-48-3657), AN ORALLY-ACTIVE IIB IIIA ANTAGONIST, ADMINISTERED ALONE OR IN COMBINATION WITH HEPARIN, ASPIRIN, AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN BEAGLES/

      Journal of cardiovascular pharmacology
    94. MATSUNO H; KOZAWA O; NIWA M; ITO T; TANABE K; NISHIDA M; HAYASHI H; UEMATSU T
      EFFECT OF GR144053, A FIBRINOGEN-RECEPTOR ANTAGONIST, ON THROMBUS FORMATION AND VASCULAR PATENCY AFTER THROMBOLYSIS BY TPA IN THE INJURED CAROTID-ARTERY OF THE HAMSTER

      Journal of cardiovascular pharmacology
    95. COHEN JE; GINSBERG HJ; EMERY D; SCHWARTZ ML
      FATAL SPONTANEOUS SPINAL EPIDURAL HEMATOMA FOLLOWING THROMBOLYSIS FORMYOCARDIAL-INFARCTION

      Surgical neurology
    96. GEBEL JM; SILA CA; SLOAN MA; GRANGER CB; MAHAFFEY KW; WEISENBERGER J; GREEN CL; WHITE HD; GORE JM; WEAVER WD; CALIFF RM; TOPOL EJ
      THROMBOLYSIS-RELATED INTRACRANIAL HEMORRHAGE - A RADIOGRAPHIC ANALYSIS OF 244 CASES FROM THE GUSTO-1 TRIAL WITH CLINICAL CORRELATION

      Stroke
    97. LEDRICK D; KHALIL H; TITA J; MAHAJAN V
      SUDDEN APPEARANCE OF A MASS ON CHEST-X-RAY

      Postgraduate medical journal
    98. DANGAS G; FIER C; AMBROSE JA
      THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION

      Medicamentos de actualidad
    99. MURPHY NP; PRATICO D; FITZGERALD DJ
      FUNCTIONAL RELEVANCE OF THE EXPRESSION OF LIGAND-INDUCED BINDING-SITES IN THE RESPONSE TO PLATELET GP LLB LLLA ANTAGONISTS IN-VIVO/

      The Journal of pharmacology and experimental therapeutics
    100. DENHEIJER P; VERMEER F; AMBROSIONI E; SADOWSKI Z; LOPEZSENDON JL; VONESSEN R; BEAUFILS P; THADANI U; ADGEY J; PIERARD L; BRINKER J; DAVIES RF; SMALLING RW; WALLENTIN L; CASPI A; PANGERL A; TRICKETT L; HAUCK C; HENRY D; CHEW P
      EVALUATION OF A WEIGHT-ADJUSTED SINGLE-BOLUS PLASMINOGEN-ACTIVATOR INPATIENTS WITH MYOCARDIAL-INFARCTION - A DOUBLE-BLIND, RANDOMIZED ANGIOGRAPHIC TRIAL OF LANOTEPLASE VERSUS ALTEPLASE

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 19:48:30